serw-MX  [xml]  
 


    
 DeCS Categories

D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.065 Androgen Antagonists .
D06.347.065.249 Androgen Receptor Antagonists .
D06.347.295 Estrogen Antagonists .
D06.347.295.500 Estrogen Receptor Antagonists .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.364 Endothelin Receptor Antagonists .
D27.505.519.364.750 Endothelin B Receptor Antagonists .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.086 5-Lipoxygenase-Activating Protein Inhibitors .
D27.505.519.389.108 Adenylyl Cyclase Inhibitors .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.050 Adrenergic Agents .
D27.505.519.625.050.100 Adrenergic Agonists .
D27.505.519.625.050.100.100 Adrenergic alpha-Agonists .
D27.505.519.625.050.100.100.100 Adrenergic alpha-1 Receptor Agonists .
D27.505.519.625.050.100.100.200 Adrenergic alpha-2 Receptor Agonists .
D27.505.519.625.050.100.200 Adrenergic beta-Agonists .
D27.505.519.625.050.100.200.100 Adrenergic beta-1 Receptor Agonists .
D27.505.519.625.150 Dopamine Agents .
D27.505.519.625.150.175 Dopamine Antagonists .
D27.505.519.625.150.175.500 Dopamine D2 Receptor Antagonists .
D27.505.519.625.725 Purinergic Agents .
D27.505.519.625.725.200 Purinergic Agonists .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.065 Androgen Antagonists .
D27.505.696.399.450.065.249 Androgen Receptor Antagonists .
D27.505.696.399.450.327 Estrogen Antagonists .
D27.505.696.399.450.327.650 Estrogen Receptor Antagonists .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.050 Adrenergic Agents .
D27.505.696.577.050.100 Adrenergic Agonists .
D27.505.696.577.050.100.100 Adrenergic alpha-Agonists .
D27.505.696.577.050.100.100.100 Adrenergic alpha-1 Receptor Agonists .
D27.505.696.577.050.100.100.200 Adrenergic alpha-2 Receptor Agonists .
D27.505.696.577.050.100.200 Adrenergic beta-Agonists .
D27.505.696.577.050.100.200.100 Adrenergic beta-1 Receptor Agonists .
D27.505.696.577.150 Dopamine Agents .
D27.505.696.577.150.175 Dopamine Antagonists .
D27.505.696.577.150.175.500 Dopamine D2 Receptor Antagonists .
D27.505.696.577.725 Purinergic Agents .
D27.505.696.577.725.200 Purinergic Agonists .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Androgen Receptor Antagonists .
Antagonists, Androgen Receptor .
Receptor Antagonists, Androgen .
Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. .
1.00
 
Adenylyl Cyclase Inhibitors .
Adenylate Cyclase Inhibitors .
Cyclase Inhibitors, Adenylate .
Cyclase Inhibitors, Adenylyl .
Inhibitors, Adenylate Cyclase .
Inhibitors, Adenylyl Cyclase .
Compounds that bind to and inhibit the action of ADENYLYL CYCLASES. .
0.72
 
Purinergic Agonists .
Purinergic Receptor Agonists .
Purinoceptor Agonists .
Agonists, Purinergic .
Agonists, Purinergic Receptor .
Agonists, Purinoceptor .
Receptor Agonists, Purinergic .
Compounds that bind to and activate PURINERGIC RECEPTORS. .
0.69
 
Estrogen Receptor Antagonists .
Estradiol Receptor Antagonists .
Antagonists, Estradiol Receptor .
Antagonists, Estrogen Receptor .
Receptor Antagonists, Estradiol .
Receptor Antagonists, Estrogen .
Compounds and drugs that bind to and block or inhibit the activation of ESTROGEN RECEPTORS. .
0.68
 
5-Lipoxygenase-Activating Protein Inhibitors .
FLAP Inhibitors .
5 Lipoxygenase Activating Protein Inhibitors .
Inhibitors, 5-Lipoxygenase-Activating Protein .
Inhibitors, FLAP .
Protein Inhibitors, 5-Lipoxygenase-Activating .
Compounds that bind to and inhibit the action of 5-LIPOXYGENASE-ACTIVATING PROTEINS. .
0.67
 
Adrenergic alpha-1 Receptor Agonists .
Adrenergic alpha-1 Agonists .
Adrenergic alpha-1 Receptor Agonist .
Adrenergic alpha1-Agonists .
Adrenergic alpha 1 Agonists .
Adrenergic alpha 1 Receptor Agonist .
Adrenergic alpha 1 Receptor Agonists .
Adrenergic alpha1 Agonists .
Agonists, Adrenergic alpha-1 .
alpha1-Agonists, Adrenergic .
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. .
0.62
 
Adrenergic alpha-2 Receptor Agonists .
Adrenergic alpha-2 Agonists .
Adrenergic alpha-2 Receptor Agonist .
Adrenergic alpha2-Agonists .
Adrenergic alpha 2 Agonists .
Adrenergic alpha 2 Receptor Agonist .
Adrenergic alpha 2 Receptor Agonists .
Adrenergic alpha2 Agonists .
Agonists, Adrenergic alpha-2 .
alpha-2 Agonists, Adrenergic .
alpha2-Agonists, Adrenergic .
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. .
0.62
 
Adrenergic beta-1 Receptor Agonists .
Adrenergic beta-1 Agonists .
Adrenergic beta-1 Receptor Agonist .
Adrenergic beta1-Agonists .
Adrenergic beta 1 Agonists .
Adrenergic beta 1 Receptor Agonist .
Adrenergic beta 1 Receptor Agonists .
Adrenergic beta1 Agonists .
Agonists, Adrenergic beta-1 .
beta-1 Agonists, Adrenergic .
beta1-Agonists, Adrenergic .
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. .
0.60
 
Dopamine D2 Receptor Antagonists .
Dopamine D2 Antagonists .
Receptor Antagonists, Dopamine D2 .
Antagonists, Dopamine D2 .
D2 Antagonists, Dopamine .
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. .
0.60
 
Endothelin B Receptor Antagonists .
Antagonists, Endothelin B Receptor .
Blockers, Endothelin B Receptor .
Endothelin B Receptor Blockers .
Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN B RECEPTORS. .
0.60